Unknown NA INTERVENTIONAL 2-arm NCT02219191

Puerarin Versus Atorvastatin in Treating Metabolism Syndrome in Patients With Chronic Rheumatic Diseases

The Effect of Puerarin Tablets in Treating Metabolism Syndrome in Patients With Chronic Rheumatic Diseases

Sponsor: Chengdu PLA General Hospital

Interventions Atorvastatin tablet 20 mg puerarin tablet 50 mg

Updated 7 times since 2017 Last updated: Mar 31, 2017 Started: Aug 31, 2014 Primary completion: Dec 31, 2018 Completion: Dec 31, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Rheumatoid Arthritis, this trial is ongoing. The trial is conducted by Chengdu PLA General Hospital and has accumulated 7 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Unknown NA
Sep 2024 — Sep 2025 [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Apr 2019 — Jan 2021 [monthly]

Unknown Status NA

Status: Active Not Recruiting → Unknown Status

▶ Show 2 earlier versions

Jun 2018 — Apr 2019 [monthly]

Active Not Recruiting NA
Jan 2017 — Jun 2018 [monthly]

Active Not Recruiting NA

First recorded

Aug 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Chengdu PLA General Hospital

Data source: Chengdu PLA General Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Chengdu, China